COVID-19 in the Cancer Patient.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 32543802.
- Also identified by DOI 10.1213/ANE.0000000000004884 and PMC identifier 7179051.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The novel coronavirus disease 2019 (COVID-19) was first reported in China in December 2019. Since then, it has spread across the world to become one of the most serious life-threatening pandemics since the influenza pandemic of 1918. This review article will focus on the specific risks and nuanced considerations of COVID-19 in the cancer patient. Important perioperative management recommendations during this outbreak are emphasized, in addition to discussion of current treatment techniques and strategies available in the battle against COVID-19.
Medical subject headings
- Coronavirus Infections
- Neoplasms
- Pneumonia, Viral